EGFR and fungal infectious disease: These results are consistent with a model in which R. delemar stimulates EGFR signaling in vivo to facilitate endocytosis of the fungus by airway epithelial cells and raise the exciting possibility of repurposing an FDA-approved drug to potentially control these invasive fungal infections.